The Biomedical Research Institute (BRI) is a 501 (c)(3) nonprofit research company committed to improving global health through a variety of research and service activities. For over 40 years, with the financial support of the NIH, our mission has been to reduce the global health burden imposed by infectious diseases of the developing world in general, and targeting Schistosomiasis, a deadly parasitic disease in particular. This disease is responsible for 250,000 deaths annually in 78 countries, causing significant morbidity primarily in sub-Saharan Africa and parts of mediterranean Europe, South America and rural China.
To carry out its Schistosomiasis lifecycle maintenance work, BRI maintains an AAALAC accredited small animal facility that is registered with the USDA and maintains an Animal Welfare Assurance permit through the NIH Office of Laboratory Animal Welfare (OLAW). All animal care and use activities are conducted in compliance with applicable local, state, and federal laws and regulations and are managed by our institutional animal care and use committee (IACUC).
To learn more about BRI’s schistosomiasis reagent supply services, click on the following link NIAID Schistosomiasis Resource Center. NOTE: We offer courses in maintenance of the schistosomiasis life cycle and on molecular methods relevant to schistosomiasis. More course information can be found here.
BRI also has a low temperature (-20C, -80C, -196C) biorepository where it stores more than five million human clinical samples in support of the AIDS Clinical Trials Group (ACTG) which includes clinical samples from adult, adolescent and pediatric AIDS clinical research vaccine trials supported by NIH/NIAID. With its numerous government and private clients, BRI has cataloged, stored and distributed millions of biological reagents supporting basic research efforts worldwide.
To obtain more information about BRI’s low-temperature storage services, click on the link to the BRI Biorepository.
BRI brings together a wide variety of scientific, technical and business expertise toward the common goal of improving global health.